| Literature DB >> 29196062 |
Richard T Liu1, Katie M Scopelliti2, Sarah K Pittman3, Alejandra S Zamora4.
Abstract
BACKGROUND: Non-suicidal self-injury is being increasingly recognised as a prominent public health concern. Identification of early and modifiable risk factors is necessary to advance the screening and intervention efforts, particularly early detection of at-risk individuals. We aimed to examine childhood maltreatment, including its specific subtypes, in relation to non-suicidal self-injury.Entities:
Mesh:
Year: 2017 PMID: 29196062 PMCID: PMC5743605 DOI: 10.1016/S2215-0366(17)30469-8
Source DB: PubMed Journal: Lancet Psychiatry ISSN: 2215-0366 Impact factor: 27.083
Figure 1PRISMA flow chart of literature search
Study characteristics
| Study Author(s) (year) | N | % Female | Mean Age | Sample | Childhood Maltreatment
| Non-Suicidal Self-Injury
| ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Measure(s) | Format | Form(s) | Measure | Format | Time Frame | |||||
| Akyuz et al. (2005) | 628 | 100 | 34.8 | Community | CANQ | Q | CEA, CPA, CSA | SSM | Q | Lifetime |
| Arens et al. (2012) | 407 | 65.0 | 20.3 | Community | CATS | Q | Overall | DSHI | Q | Lifetime |
| Arens et al. (2014) | 600 | 73.0 | 19.7 | Community | CATS | Q | Overall, CPA, CPN, CSA | DSHI | Q | Lifetime |
| Asarnow et al. (2011) | 250 | 65.2 | 15.8 | Clinical | K-SADS | I | CPN, CSA | K-SADS | I | Lifetime |
| Auerbach et al. (2014) | 194 | 74.2 | 15.5 | Clinical | CTQ | Q | Overall, CPA, CSA | SITBI | I | 1 month |
| Baiden et al. (2017) | 2,038 | 38.9 | 12.5 | Clinical | ChYMH | I | CEA, CPA, CSA | ChYMH | I | Lifetime |
| Bernegger et al. (2015) | 255 | 56.9 | – | Clinical | CTQ | Q | Overall, CEA, CEN, CPA, CPN, CSA | VI-SURIAS | Q | Lifetime |
| Bresin et al. (2013) | 446 | 30.4 | 30.3 | At-risk | CTQ | Q | CEA, CEN, CPA, CPN, CSA | LHA | I | Lifetime |
| Briere & Gil (1998) Study 1 | 927 | 50.0 | 46.0 | Community | TES | Q | CSA | TSI | Q | 6 months |
| Briere & Gil (1998) Study 2 | 390 | 77.9 | 36.0 | Clinical | CMIS | I | CSA | TSI | Q | 6 months |
| Brown et al. (1999) | 117 | 98.3 | 24.7 | Clinical | SLEI | Q | CPA, CSA | SSM | Q | Lifetime |
| Buckholdt et al. (2009) | 117 | 76.3 | 21.0 | Community | EAC | Q | CEN | DSHI | Q | Lifetime |
| Burke et al. (2017) | 520 | 76.0 | 20.6 | At-risk | CTQ | Q | CEA, CEN, CPA, CPN, CSA | FAFSI | Q | Lifetime |
| Buser & Hackney (2012) | 390 | 66.0 | 20.3 | Community | EASE-PI | Q | CEA | FASM | Q | 1 year |
| Buser et al. (2015) | 648 | 74.0 | 20.5 | Community | EASE-PI | Q | CEA | FASM | Q | 1 year |
| Cater et al. (2014) | 2,500 | 52.6 | 22.2 | Community | JVQ | Q | CEA, CPA, CPN, CSA | SSM | Q | Lifetime |
| Cerutti et al. (2011) | 234 | 50.4 | 16.5 | Community | LSC-R | Q | CEA, CPA, CPN, CSA | DSHI | Q | Lifetime |
| Chapman et al. (2014) | 104 | 100 | 31.9 | At-risk | CTQ | Q | CEN, CPN, CSA | LPC-2 | I | Lifetime |
| Claes & Vandereycken (2007) | 65 | 100 | 21.7 | Clinical | TEQ | Q | CPA, CSA | SIQ | Q | 1 year |
| Croyle & Waltz (2007) | 216 | 55.0 | 20.1 | Community | TES | Q | CEA, CSA | SHIF | Q | 3 years |
| Darke & Torok (2013) | 300 | 33.0 | 37.1 | Clinical | CTA | I | CPA | SSM | I | Lifetime |
| Di Pierro et al. (2012) | 267 | 70.4 | 17.0 | Community | BCI | I | CPA, CPN, CSA | SIQ | Q | Lifetime |
| Evren & Evren (2005) | 136 | 0.0 | 36.4 | Clinical | CANQ | Q | CEA, CPA, CSA | SSM | I | Lifetime |
| Evren et al. (2006) | 112 | 0.0 | 33.8 | Clinical | CANQ | Q | CEA, CPA, CSA | SSM | I | Lifetime |
| Evren et al. (2008) | 176 | 0.0 | 43.1 | Clinical | SSM | Q | Overall | SSM | I | Lifetime |
| Evren et al. (2012) | 200 | 0.0 | – | Clinical | CTQ | Q | CEA, CEN, CPA, CPN, CSA | SMBQ | I | Lifetime |
| Gladstone et al. (2004) | 125 | 100 | 36.9 | Clinical | SSM | I | CSA | SSM | I | Lifetime |
| Glassman et al. (2007) | 86 | 77.9 | 17.0 | Mixed | CTQ | Q | CEA, CEN, CPA, CPN | SITBI | I | 1 year |
| Gorodetsky et al. (2016) | 614 | 0.0 | 40.3 | At-risk | CTQ | Q | Overall | SSM | I | Lifetime |
| Gratz (2006) | 200 | 100 | 23.3 | Community | API, PBI | Q | Overall, CEN, CPA, CSA | DSHI | Q | Lifetime |
| Gratz and Chapman (2007) | 97 | 0.0 | 22.7 | Community | API, PBI | Q | CEN, CPA | DSHI | Q | Lifetime |
| Gratz et al. (2002) | 133 | 66.9 | 22.7 | Community | API, DAS, PBI | Q | CEN, CPA, CPN, CSA | DSHI | Q | Lifetime |
| Isohookana et al. (2013) | 508 | 59.1 | 15.4 | Clinical | K-SADS | I | CPA, CSA | K-SADS | I | Lifetime |
| Jaquier et al. (2013) | 212 | 100 | 36.6 | At-risk | CTQ | Q | CEA, CPA, CSA | DSHI | Q | Lifetime |
| Kaess et al. (2013) | 125 | 50.4 | 17.1 | Clinical | CECA.Q | Q | Overall, CEN, CPA, CPN, CSA | FASM | Q | 1 year |
| Kaplan et al. (2016) | 48 | 100 | 17.2 | Clinical | CTQ | Q | CSA | SITBI | I | 1 and 12 months |
| Kara et al. (2015) | 295 | 24.4 | 14.3 | At-risk | SSM | I | CSA | SSM | I | Lifetime |
| Karagöz & Da (2015) | 79 | 0.0 | 41.9 | Clinical | CTQ | Q | CPA, CSA | SSM | I | Lifetime |
| Lipschitz et al. (1999) | 71 | 52.2 | 14.7 | Clinical | CTQ | Q | CPN | SSM | I | Lifetime |
| Lüdtke et al. (2016) | 72 | 100 | 16.1 | Clinical | CECA.Q | Q | CEN, CPA, CPN, CSA | SSM | I | Lifetime |
| Maloney et al. (2010) | 697 | 44.8 | 35.9 | Clinical | CTA | I | Overall, CEA, CEN, CPA, CSA | COGA | I | Lifetime |
| Martin et al. (2011) | 1,170 | 74.0 | 19.3 | Community | PBI, PRP, SSM | Q | CEN, CSA | OSI | Q | 6 months |
| Martin et al. (2016) | 957 | 78.1 | 20.1 | Community | CCMS | Q | Overall | OSI | Q | Lifetime |
| Muehlenkamp et al. (2010) | 1,855 | 66.0 | 19.7 | Community | AMQ | Q | CPA, CSA | DSHI | Q | Lifetime |
| Nijman et al. (1999) | 47 | 48.0 | 37.5 | Clinical | CTQ | Q | Overall, CEA, CEN, CPA, CPN, CSA | SSM | I | Lifetime |
| Parker et al. (2005) Study 1 | 112 | 60.7 | 36.4 | Clinical | MOPS, PBI | Q | CPA, CSA | SSM | I | Lifetime |
| Parker et al. (2005) Study 2 | 98 | 83.7 | 33.7 | Clinical | MOPS, PBI | Q | CPA, CSA | SSM | I | Lifetime |
| Parker et al. (2005) Study 3 | 76 | 80.6 | 33.4 | Clinical | MOPS, PBI | Q | Overall, CPA, CSA | SSM | I | Lifetime |
| Peh et al. (2017) | 108 | 59.3 | 17.0 | Clinical | CTQ | Q | Overall | FASM | Q | 1 year |
| Rabinovitch et al. (2015) | 140 | 100 | 15.3 | At-risk | CPS records | – | CPA, CSA | C-SSRS | I | Lifetime |
| Reddy et al. (2013) | 71 | 56.0 | 14.7 | At-risk | CTQ | Q | CSA | FASM | Q | 1 year |
| Reichl et al. (2016) | 52 | 92.3 | 16.3 | Mixed | CECA | I | Overall, CEA, CEN, CPA, CPN, CSA | SITBI | I | Lifetime |
| Roe-Sepowitz (2007) | 256 | 100 | 35.5 | At-risk | CMIS | Q | CEA, CPA, CSA | TSI | Q | Lifetime |
| Stewart et al. (2014) | 2,013 | 45.5 | 17.7 | Clinical | ChYMH | I | CEA, CPA, CSA | ChYMH | I | 1 year |
| Swannell et al. (2012) | 10,719 | 61.7 | 52.1 | Community | SSM | I | CPA, CPN, CSA, | SSM | I | 1 year |
| Taliaferro et al. (2012) | 59,276 | 46.6 | – | Community | SSM | Q | CPA, CSA | SSM | Q | 1 year |
| Tatnell et al. (2016) | 2,550 | 68.0 | 13.9 | Community | ALES | Q | CPA, CSA | SHBQ | Q | Lifetime |
| Thomassin et al. (2016) | 95 | 58.0 | 14.2 | Clinical | CTQ | Q | CEA, CPA, CSA | DSHI | Q | Lifetime |
| Tresno et al. (2012) | 215 | 76 | 19.8 | Community | CATS | Q | CPN | DSHI | Q | Lifetime |
| Tresno et al. (2013) | 313 | 50 | 19.0 | Community | CATS | Q | CPN | DSHI | Q | Lifetime |
| Tsai et al. (2011) | 742 | 23.8 | 17.0 | Community | SSM | Q | CSA | SSM | Q | Lifetime |
| Turell & Armsworth (2000) | 84 | 100 | 32.5 | At-risk | SSM | Q | CEA, CPA, CSA | SSM | Q | Lifetime |
| Tyler et al. (2003) | 417 | 56.3 | 17.4 | At-risk | PC-CTS, SSM | Q | CSA | FASM | Q | Lifetime |
| Wachter et al. (2009) | 58 | 72.4 | 37.1 | Clinical | CTQ | Q | CEA, CEN, CPA, CPN, CSA | DSHI | Q | Lifetime |
| Wan et al. (2015) | 14,211 | 52.8 | 15.1 | Community | ACE Tool | Q | Overall, CEA, CPA, CSA | SSM | Q | 1 year |
| Weierich & Nock (2008) | 44 | 84.1 | 17.2 | Mixed | CTQ | Q | CSA | SITBI | I | 1 month |
| Weismoore & Esposito-Smythers (2010) | 183 | 71.4 | – | Clinical | K-SADS | I | CPA, CSA | K-SADS | I | 1 year |
| Yates et al. (2008) | 155 | 51.6 | 26.0 | At-risk | Multiple sources | Mixed | CPA, CPN, CSA | SSM | I | Lifetime |
| Zanarini et al. (2002) | 290 | 80.3 | 26.9 | Clinical | CEQ-R | I | CSA | LSDS | I | Lifetime |
| Zanarini et al. (2011) | 290 | 80.3 | 26.9 | Clinical | CEQ-R | I | CEN | LSDS | I | 10 years |
| Zetterqvist et al. (2014) | 816 | – | – | Community | LYLES | Q | CEA, CPA, CSA | FASM | Q | 1 year |
| Zlotnick et al. (1996) | 148 | 100 | 33.0 | Clinical | SAQ | Q | CSA | SII | Q | 3 months |
| Zoroglu et al. (2003) | 818 | 61.1 | 15.9 | Community | CANQ | Q | Overall, CEA, CPA, CSA | SSM | Q | Lifetime |
| Zweig-Frank et al. (1994) | 150 | 100 | 29.0 | Clinical | SSM | I | CSA | DIB-R | I | 2 years |
Note: ACE Tool = Centers for Disease Control and Prevention Short Adverse Childhood Experiences Tool; ALES =Adolescent Life Events Scale; AMQ = About Me Questionnaire; API = Abuse and Perpetration Inventory; BCI = Boricua Child Interview; CANQ = Childhood Abuse and Neglect Questionnaire; CATS = Child Abuse and Trauma Scale; CCMS = Comprehensive Childhood Maltreatment Scale; CECA = Childhood Experiences of Care and Abuse Interview; CECA.Q = Childhood Experiences of Care and Abuse Questionnaire; CEQ-R= Revised Childhood Experiences Questionnaire; ChYMH = Child and Your Mental Health Instrument; CMIS = Childhood Maltreatment Interview Schedule; COGA SSAGA-II= Collaborative Study on the Genetics of Alcoholism Semi-Structured Assessment for the Genetics of Alcoholism II; CPS = child protective services; C-SSRS = Columbia-Suicide Severity Rating Scale; CTA= Christchurch Trauma Assessment; CTQ = Childhood Trauma Questionnaire; DAS=Disruptions in Attachment Survey; DIB-R= Diagnostic Interview for Borderlines – Revised; DSHI= Deliberate Self-Harm Inventory; EAC=Emotions as a Child Scales; EASE-PI= Exposure To Abusive and Supportive Environments Parenting Inventory; FAFSI= Form and Function of Self Injury Scale; FASM = Functional Assessment of Self-Mutilation; JVQ=Juvenile Victimization Questionnaire; K-SADS = Kiddie Schedule for Affective Disorders and Schizophrenia; LHA= Lifetime History of Aggression; LPC-2= Lifetime Parasuicide Count-2; LSC-R= Life Stressor Checklist-Revised; LSDS= Lifetime Self-Destructiveness Scale; LYLES = Linköping Youth Life Experience Scale; MOPS = Measure of Parental Style; OSI= Ottawa Self-Injury Inventory; PBI= Parental Bonding Instrument; PC-CTS= Parent-Child Conflict Tactics Scale; PRP= Personal and Relationships Profile; SAQ = Sexual Assault Questionnaire; SHBQ= Self-Harm Behavior Questionnaire; SHIF= Self-Harm Information Form; SII = Self-Injury Inventory; SIQ= Self-Injury Questionnaire; SITBI = Self-Injurious Thoughts and Behaviors Interview; SLEI = Sexual Life Events Inventory; SMBQ= Self-mutilative Behavior Questionnaire; SSM = study-specific measure; TEQ= Traumatic Experiences Questionnaire; TES = Traumatic Events Survey; TSI = Trauma Symptom Inventory; VI-SURIAS = Viennese Suicide Risk Assessment Scale
I = Interview; Q = Questionnaire
CEA = childhood emotional abuse; CEN = childhood emotional neglect; CPA = childhood physical abuse; CPN = childhood physical neglect; CSA = childhood sexual abuse
Studies with identical superscripts were drawn from same or overlapping samples but presented unique data included in this review.
The sample size, mean age, and percentage female for participants included in relevant analyses, rather than of the entire study sample, are presented and were incorporated in moderator analyses whenever available. For ease of presentation, whenever the sample size varied across multiple relevant analyses within a study, the largest cumulative sample size across these analyses is presented here, and the sample size used in each analysis was retained in the relevant meta-analysis for purposes of obtaining weighted effect sizes.
Separate effects were reported by sex. The proportion of the overall sample that was female is presented here.
Although childhood abuse was assessed prospectively, its cross-sectional relation with NSSI was reported at each time-point. The analysis of this relation at baseline provided the largest sample size and was thus included in the current review.
The PBI was also used to assess childhood maltreatment. This study did not include it, however, in quantitative analyses.
Univariate associations between childhood maltreatment and non-suicidal self-injury.
| Effect Size Analyses
| Heterogeneity | Publication Bias Analyses
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NTotal | Mean Age | Mean Age | OR | 95% CI | Orwin’s fail-safe | Egger’s | Trim-and-fill
| ||||||
| OR | 95% CI | ||||||||||||
| Overall Childhood Maltreatment | 18 | 19,537 | 15.17 | 28.00 | 3·42 | 2·74 – 4·26 | <·0001 | 82·82% | <·0001 | 215 | ·76 | 3·12 | 2·51 – 3·87 |
| Childhood Sexual Abuse | 63 | 48,246 | 15.15 | 39.73 | 2·65 | 2·33 – 3·03 | <·0001 | 68·80% | <·0001 | 583 | ·83 | 2·34 | 2·04 – 2·68 |
| Childhood Physical Abuse | 51 | 37,821 | 15.05 | 39.80 | 2·31 | 1·97 – 2·69 | <·0001 | 78·22% | <·0001 | 397 | ·05 | 2·31 | 1·97 – 2·69 |
| Childhood Physical Neglect | 26 | 17,141 | 16.51 | 42.68 | 2·22 | 1·75 – 2·80 | <·0001 | 73·72% | <·0001 | 192 | ·97 | 2·16 | 1·71 – 2·73 |
| Childhood Emotional Abuse | 29 | 27,768 | 15.16 | 26.52 | 3·03 | 2·59 – 3·54 | <·0001 | 79·18% | <·0001 | 309 | ·37 | 2·77 | 2·38 – 3·23 |
| Childhood Emotional Neglect | 19 | 3,468 | 16.51 | 28.26 | 1·84 | 1·45 – 2·34 | <·0001 | 72·68% | <·0001 | 103 | <·01 | 1·63 | 1·29 – 2·05 |
Note: k = number of unique effects; OR = pooled odds ratio; CI = confidence interval
An outlier was excluded from analyses for childhood physical abuse and sexual abuse, respectively.
Participants < age 18 are classified here as adolescents, and those ≥18 are classified as adults.
Univariate and multivariate moderator analyses.
| Univariate Moderator Analyses
| Multivariate | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Effect Size Analyses
| Heterogeneity Analyses
| Meta-Regression Analyses
| |||||||||
| N | OR | 95% CI | |||||||||
| ·67 | |||||||||||
| Age (Categorical) | 17 | 19,412 | <·01 | ||||||||
| Adolescent | 6 | 4·44 | 4·07–4·84 | <·0001 | 1·71% | ·41 | ·43 | ·13 | |||
| Adult | 11 | 2·86 | 2·16–3·78 | <·0001 | 67·76% | <·01 | |||||
| Age (Continuous) | 16 | 19,282 | <·01 | ·53 | |||||||
| Percentage Female | 18 | 19,537 | <·01 | ·62 | |||||||
| Sample Type | 17 | 19,485 | ·15 | ||||||||
| Childhood Maltreatment Measure | – | – | – | – | – | – | |||||
| NSSI Measure | 18 | 19,537 | ·11 | ||||||||
| NSSI Timeframe | 17 | 19,343 | <·01 | ||||||||
| 12-Month | 4 | 4·50 | 4·12–4·90 | <·0001 | 0% | ·46 | ·15 | ·62 | |||
| Lifetime | 13 | 3·06 | 2·34–3·99 | <·0001 | 70·10% | <·0001 | |||||
| Age (Categorical) | 62 | 48,121 | ·44 | ||||||||
| Age (Continuous) | 58 | 46,792 | <·01 | ·54 | |||||||
| Percentage Female | 62 | 48,246 | <·01 | ·49 | |||||||
| Sample Type | 61 | 48,150 | ·09 | ||||||||
| Childhood Maltreatment Measure | 61 | 48,091 | ·66 | ||||||||
| NSSI Measure | 63 | 48,246 | ·10 | ||||||||
| NSSI Timeframe | 62 | 48,094 | <·01 | ||||||||
| 12-Month | 15 | 3·52 | 2·84–4·37 | <·0001 | 67·10% | <·01 | |||||
| Lifetime | 47 | 2·38 | 2·05–2·76 | <·0001 | 60·48% | <·0001 | |||||
| Age (Categorical) | 50 | 37,696 | ·26 | ||||||||
| Age (Continuous) | 46 | 36,367 | ·02 | ·07 | |||||||
| Percentage Female | 50 | 37,821 | <·01 | ·29 | |||||||
| Sample Type | 49 | 37,683 | <·0001 | ||||||||
| Clinical | 32 | 1·78 | 1·56–2·04 | <·0001 | 34·30% | ·03 | |||||
| Community | 17 | 3·29 | 2·64–4·11 | <·0001 | 78·80% | <·0001 | |||||
| Childhood Maltreatment Measure | 48 | 37,526 | ·52 | ||||||||
| NSSI Measure | 51 | 37,821 | ·13 | ||||||||
| NSSI Timeframe | 50 | 37,627 | ·14 | ||||||||
| ·68 | |||||||||||
| Age (Categorical) | 25 | 17,016 | ·81 | ||||||||
| Age (Continuous) | 23 | 16,686 | ·02 | ·09 | |||||||
| Percentage Female | 26 | 17,141 | <·01 | ·28 | |||||||
| Sample Type | 24 | 17,003 | <·01 | ||||||||
| Clinical | 13 | 1·60 | 1·19–2·15 | <·01 | 55·76% | <·01 | |||||
| Community | 11 | 2·87 | 2·22–3·71 | <·0001 | 60·77% | <·01 | ·50 | <·01 | |||
| Childhood Maltreatment Measure | 24 | 16,986 | ·26 | ||||||||
| NSSI Measure | 26 | 17,141 | ·66 | ||||||||
| NSSI Timeframe | 26 | 17,141 | <·01 | ||||||||
| 12-Month | 4 | 3·87 | 2·59–5·77 | <·0001 | 39·45% | ·18 | ·61 | ·02 | |||
| Lifetime | 22 | 2·01 | 1·58–2·54 | <·0001 | 67·61% | <·0001 | |||||
| ·77 | |||||||||||
| Age (Categorical) | 29 | 27,768 | ·83 | ||||||||
| Age (Continuous) | 25 | 26,497 | <·01 | ·59 | |||||||
| Percentage Female | 28 | 27,768 | <·01 | ·10 | |||||||
| Sample Type | 27 | 27,630 | ·03 | ||||||||
| Clinical | 16 | 2·69 | 2·08–3·47 | <·0001 | 75·28% | <·0001 | |||||
| Community | 11 | 3·66 | 3·31–4·04 | <·0001 | 29·43% | ·17 | <·01 | ·77 | |||
| Childhood Maltreatment Measure | 29 | 27,768 | <·0001 | ||||||||
| Interview | 4 | 1·85 | 1·55–2·21 | <·0001 | 19·88% | ·29 | |||||
| Questionnaire | 25 | 3·32 | 2·91–3·79 | <·0001 | 60·67% | <·0001 | ·16 | ·44 | |||
| NSSI Measure | 29 | 27,768 | <·01 | ||||||||
| Interview | 10 | 2·19 | 1·64–2·92 | <·0001 | 71·92% | <·01 | |||||
| Questionnaire | 19 | 3·74 | 3·50–3·99 | <·0001 | 0% | ·61 | ·56 | <·01 | |||
| NSSI Timeframe | 29 | 27,768 | ·51 | ||||||||
| Age (Categorical) | 18 | 3,343 | ·24 | ||||||||
| Age (Continuous) | 16 | 3,013 | <·01 | ·09 | |||||||
| Percentage Female | 19 | 3,468 | <·01 | ·59 | |||||||
| Sample Type | 17 | 3,330 | ·02 | ||||||||
| Clinical | 12 | 1·53 | 1·19–1·97 | <·01 | 67.98% | <·01 | |||||
| Community | 5 | 2·45 | 1·78–3·36 | <·0001 | 0% | .90 | |||||
| Childhood Maltreatment Measure | 19 | 3,468 | ·68 | ||||||||
| NSSI Measure | 19 | 3,468 | ·82 | ||||||||
| NSSI Timeframe | – | – | – | – | – | – | |||||
Note: k = number of unique effects; OR = pooled odds ratio; CI = confidence interval
In analyses of sample type, at-risk and clinical samples were combined and compared to community samples.
Not enough observations from studies employing interview measures of childhood maltreatment (k = 2) were available for moderator analysis.
All but two studies analyzed lifetime history of NSSI in relation to childhood maltreatment, and thus moderator analysis was not conducted.
The category with the smallest effect size in univariate moderator analysis served as the reference group in the corresponding meta-regression analysis.
Figure 2Funnel plot for effect sizes in the meta-analyses. The vertical line indicates the weighted mean effect. Open circles indicate observed effects for actual studies, and closed circles indicate imputed effects for studies believed to be missing due to publication bias. The clear diamond reflects the unadjusted weighted mean effect size, whereas the black diamond reflects the weighted mean effect size after adjusting for publication bias.
2a. Overall childhood maltreatment and non-suicidal self-injury
2b. Childhood sexual abuse and non-suicidal self-injury
2c. Childhood physical abuse and non-suicidal self-injury
2d. Childhood physical neglect and non-suicidal self-injury
2e. Childhood emotional abuse and non-suicidal self-injury
2f. Childhood emotional neglect and non-suicidal self-injury